Yasuo Sugita

Yasuo Sugita

Auto-generated profile, based on publicly available information

Yasuo Sugita

Department of Neuropathology Neurology Center, St. Mary's Hospital Kurume Japan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2011 in Brain Tumor Pathology
Verified
Journal Article
Closed access
PDF file
MTMizuhiko Terasaki
Mizuhiko Terasaki
YSYasuo Sugita
Yasuo Sugita
FAFumiko Arakawa
Fumiko Arakawa
YOYosuke Okada
Yosuke Okada
KOKoichi Ohshima
Koichi Ohshima
MSMinoru Shigemori
Minoru Shigemori

26 November 2015 in Neuropathology
Verified
Journal Article
Open access
PDF file
YSYasuo Sugita
Yasuo Sugita
HMHiroko Muta
Hiroko Muta
KOKoichi Ohshima
Koichi Ohshima
MMMotohiro Morioka
Motohiro Morioka
YTYoshihiro Tsukamoto
Yoshihiro Tsukamoto
AKAkiyoshi Kakita
Akiyoshi Kakita
Although primary diffuse large B‐cell lymphomas of the CNS are designated as primary CNS lymphomas according to the WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue in 2008, a variety of other lymphomas (Burkitt lymphomas, EBV‐positive diffuse large B‐cell lymphoma of the elderly) and related diseases (lymphomatoid granulomatosis) that are also found in the CNS have been spotlighted in recent years. The histopathology of primary CNS Burkitt lymphomas mimics that of primary diffuse large B‐cell lymphomas of the CNS after steroid administration. Therefore, for correct diagnosis of the involved lymphoma, comprehensive fluorescent in situ hybridization analysis for c‐MYC and BCL2 is recommended in all primary CNS lymphoma cases with aggressive clinical course, multifocal involvement of the CNS, and a high proliferation index. The pathological characteristics of primary CNS EBV‐positive diffuse large B‐cell lymphoma of the elderly have similarities with those of the latency phenotype III, EBV lymphoproliferative disorders that arise in the setting of immunodeficiency. These age‐related lymphomas usually occur in elderly immunocompetent patients, and the incidence of this disease was estimated to range from 4.0% to 13.6% of all primary CNS lymphomas. Shorter overall survival has been reported for patients with this disease. Lymphomatoid granulomatosis (LYG) is a systemic, EBV‐driven, angiocentric and angiodestructive lymphoproliferative disorder. Primary LYG that shows distinct clinicopathological features compared with systemic LYG was recently reported. Finally, this review focuses on the relationship between primary CNS lymphomas and demyelinating diseases, and the concomitant use of intraoperative cytology and frozen sections that are helpful in rapid intraoperative diagnosis.

11 November 2006 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
YSYasuo Sugita
Yasuo Sugita
YTYukari Takase
Yukari Takase
DMDaisuke Mori
Daisuke Mori
OTOsamu Tokunaga
Osamu Tokunaga
ANAkihiko Nakashima
Akihiko Nakashima
MSMinoru Shigemori
Minoru Shigemori

13 March 2018 in Neuropathology
Verified
Journal Article
Closed access
PDF file
TFTakuya Furuta
Takuya Furuta
HMHiroaki Miyoshi
Hiroaki Miyoshi
SKSatoru Komaki
Satoru Komaki
FAFumiko Arakawa
Fumiko Arakawa
MMMotohiro Morioka
Motohiro Morioka
YSYasuo Sugita
Yasuo Sugita

26 June 2019 in Neuropathology
Verified
Journal Article
Closed access
PDF file
THTatsuru Hara
Tatsuru Hara
KYKenji Yagita
Kenji Yagita
YSYasuo Sugita
Yasuo Sugita

24 October 2017 in Neuropathology
Verified
Journal Article
Closed access
PDF file
YSYasuo Sugita
Yasuo Sugita
TFTakuya Furuta
Takuya Furuta
KOKoichi Ohshima
Koichi Ohshima
SKSatoru Komaki
Satoru Komaki
JMJunko Miyoshi
Junko Miyoshi
AKAkiyoshi Kakita
Akiyoshi Kakita